Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study

Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer

(2015) Simeng Wen et al.   AMERICAN JOURNAL OF PATHOLOGY

Estrogen Receptor-α is a Key Mediator and Therapeutic Target for Bladder Complications of Benign Prostatic Hyperplasia

(2015) Tristan M. Nicholson et al.   JOURNAL OF UROLOGY

Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy

(2014) C G Roehrborn et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment

(2013) Tristan M. Nicholson et al.   DIFFERENTIATION

Prostate Cancer Diagnosis Among Men With Isolated High-Grade Intraepithelial Neoplasia Enrolled Onto a 3-Year Prospective Phase III Clinical Trial of Oral Toremifene

(2013) Samir S. Taneja et al.   JOURNAL OF CLINICAL ONCOLOGY

Selective estrogen receptor modulators for BPH: new factors on the ground

(2013) M Garg et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Thulium laser resection versus plasmakinetic resection of prostates larger than 80 ml

(2013) Haibin Wei et al.   WORLD JOURNAL OF UROLOGY

Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men

(2012) Qin-Song Zeng et al.   ASIAN JOURNAL OF ANDROLOGY

Solifenacin Plus Tamsulosin Combination Treatment in Men With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction: A Randomized Controlled Trial

(2012) Steven A. Kaplan et al.   EUROPEAN UROLOGY

Involvement of estrogen receptors in prostatic diseases

(2012) Hidenori Kawashima et al.   INTERNATIONAL JOURNAL OF UROLOGY

Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40–79 years

(2011) Chun-Hou Liao et al.   Aging Male

Androgens and estrogens in benign prostatic hyperplasia: Past, present and future

(2011) Tristan M. Nicholson et al.   DIFFERENTIATION

Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia

(2011) Kevin T. McVary et al.   JOURNAL OF UROLOGY

Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

(2010) Matthew R. Smith et al.   JOURNAL OF UROLOGY

Male Lower Urinary Tract Symptoms (LUTS) and Benign Prostatic Hyperplasia (BPH)

(2010) Claus G. Roehrborn   MEDICAL CLINICS OF NORTH AMERICA

Estrogen receptor-  activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNF  mediated

(2010) S. J. McPherson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ERβ: recent understanding of estrogen signaling

(2010) Nobuhiro Sugiyama et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio

(2009) Emrah Yatkin et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia

(2009) Paloma Alonso-Magdalena et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cells

(2009) H Nomura et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Expression of steroidogenic enzymes and sex-steroid receptors in human prostate

(2008) Georges Pelletier   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer

(2008) J. A. Locke et al.   CANCER RESEARCH